This inventor holds 5 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Gwangju Institute of Science and Technology, Chonnam National University, Unique Medicare Co., Ltd.. Active years: 2016-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2024
Title: Da-Woon Jung: Innovator in Muscle Atrophy and Cardiovascular Disease Treatments
Introduction
Da-Woon Jung is a prominent inventor based in Gwangju, South Korea. He has made significant contributions to the fields of muscle atrophy and cardiovascular disease treatment. With a total of 5 patents, his work focuses on innovative compositions that address critical health issues.
Latest Patents
One of his latest patents is a composition comprising an organoselenium compound for the treatment of skeletal muscle atrophy. This application relates to a composition designed to prevent, treat, and improve skeletal muscle atrophy, which includes an organoselenium compound. The composition has shown promise in recovering the thickness of muscle fibers reduced by dexamethasone treatment. Additionally, treatment in a muscle loss model demonstrated that the composition effectively reduced damaged muscle and restored muscle mass. Therefore, it is anticipated that this composition can be effectively utilized for the treatment, prevention, or improvement of muscle atrophy.
Another significant patent involves a composition comprising a BIO compound for treating cardiovascular disease. This pharmaceutical composition includes a BIO compound ((2'Z,3′E)-6-bromoindirubin-3′-oxime) or a pharmaceutically acceptable salt thereof as an active ingredient. The composition specifically targets different types of cells in heart tissues, inducing the growth of cardiomyocytes while inhibiting the proliferation of cardiac fibroblasts. It also suppresses inflammatory mediators in macrophages, significantly aiding in the recovery of heart tissues and functions after myocardial infarction. Thus, this pharmaceutical composition holds potential for treating various cardiovascular diseases, including myocardial infarction.
Career Highlights
Da-Woon Jung has worked at notable institutions such as the Gwangju Institute of Science and Technology and Chonnam National University. His research and innovations have contributed to advancements in medical treatments, particularly in the areas of muscle and heart health.
Collaborations
Some of his coworkers include Darren R. Williams and Youngkeun Ahn, who have collaborated with him on various research projects.
Conclusion
Da-Woon Jung's innovative work in developing compositions for treating muscle atrophy and cardiovascular diseases showcases his commitment to advancing medical science. His contributions are expected to have a lasting impact on health treatments in these critical areas.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile